ArticleFrontiers in endocrinology2026
Pathological diagnosis of thyroid nodules directly from ultrasonography by a weakly supervised deep learning framework.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The management of ultrasonography (US) of thyroid nodules is often time consuming and may be inconsistent between observers. The use of deep learning (DL) can increase the speed of examinations and improve reporting consistency. To develop a novel dual attention-guided DL framework to inference histological status directly from thyroid US without expensive image-level annotations. Methods: In this retrospective analysis, patients first underwent US followed by histopathological examination by fine needle aspiration or surgical histological analysis. Two datasets from the Second Affiliated Hospital of Jiaxing University, Batch 1 and Batch 2, were used in our study for training, testing and validation of the algorithm, respectively. The proposed DL framework is named ThyUS2Path and consists of two attention modules which focus on discriminative nodule patterns in different dimensions. We compare ThyUS2Path with two commonly used state-of-the-art MIL-based methods. Results: We used 6014 images from 603 patients to build the DL framework and evaluated it on 1978 external images, five-fold cross validation AUCs of 0.754 ± 0.035 and 0.735 ± 0.029, respectively. ThyUS2Path outperformed two commonly state-of-the-art MIL-based methods significantly, namely Maxpool and Meanpool. The algorithms also obtained good prediction performance in the external test set (AUROCs of 0.70~0.80 and AUPRCs of 0.78~0.83). Conclusion: Our approach gives a feasible way to link the US phenotype with histological reports and has the potential to augment clinicians' capabilities in thyroid cancer diagnosis in a non-invasive manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.